Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 26, 2021

SELL
$3.49 - $5.51 $43,974 - $69,426
-12,600 Closed
0 $0
Q1 2021

Apr 23, 2021

BUY
$5.37 - $10.72 $67,662 - $135,072
12,600 New
12,600 $69,000
Q1 2019

Apr 19, 2019

SELL
$7.19 - $32.37 $20,851 - $93,872
-2,900 Closed
0 $0
Q2 2018

Aug 06, 2018

BUY
$7.33 - $43.15 $2,199 - $12,945
300 Added 11.54%
2,900 $103,000
Q1 2018

Apr 20, 2018

BUY
$7.19 - $33.17 $18,694 - $86,242
2,600 New
2,600 $19,000

Others Institutions Holding SLDB

About Solid Biosciences Inc.


  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $36.5M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.